Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients

Table 2 Cardiovascular characteristics in diabetic coronary artery disease patients and non-diabetic coronary artery disease patients

Parameter	Group I, n = 100	Group II, n = 100	P value1
Angiography findings
Single vessel disease	57 (57%)	35 (35%)	0.0162
Double vessel disease	27 (27%)	36 (36%)
Triple vessel disease	8 (8%)	15 (15%)
Normal angiogram	8 (8%)	14 (14%)
Stenosis in LAD as %	90.51 ± 8.51	87.85 ± 12.31	0.053
Stenosis in LCX as %	90.91 ± 8.80	82.22 ± 22.33	0.233
Stenosis in RCA as %	90.32 ± 10.15	89.26 ± 12.90	0.733
Gensini score	26 (12-44)	20 (12-40)	0.473
2D echocardiography parameters
Left atrium diameter in cm	2.93 ± 0.32	2.83 ± 0.39	0.013
Aortic root diameter in mm	2.15 ± 0.39	2.10 ± 0.40	0.273
LVEF	45.60 ± 12.04	46.70 ± 12.01	0.493
Preserved ejection fraction, LVEF ≥ 50%	38 (38%)	43 (43%)	0.692
Mild ejection fraction, LVEF 41%-49%	13 (13%)	14 (14%)
Reduced ejection fraction (LVEF < 40%)	49 (49%)	43 (43%)
AWMI	39 (39%)	39 (39%)	0.562
IWMI	26 (26%)	21 (21%)

¹P value < 0.05 is considered significant.

²χ² test.

³Mann Whitney U test.

Group I: Diabetic coronary artery disease patients; Group II: Non-diabetic coronary artery disease patients. AWMI: Anterior wall myocardial infarction; IWMI: Inferior wall myocardial infarction; LAD: Left anterior descending; LCX: Left circumflex; LVEF: Left ventricular ejection fraction; RCA: Right coronary artery.